These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17301821)

  • 1. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome.
    La Starza R; Rosati R; Roti G; Gorello P; Bardi A; Crescenzi B; Pierini V; Calabrese O; Baens M; Folens C; Cools J; Marynen P; Martelli MF; Mecucci C; Cuneo A
    Leukemia; 2007 Apr; 21(4):830-3. PubMed ID: 17301821
    [No Abstract]   [Full Text] [Related]  

  • 2. Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB-NDE1 fusion.
    Cavazzini F; Bardi A; Ciccone M; Rigolin GM; Gorello P; La Starza R; Mecucci C; Cuneo A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):67-9. PubMed ID: 19737658
    [No Abstract]   [Full Text] [Related]  

  • 3. TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemia.
    Rosati R; La Starza R; Luciano L; Gorello P; Matteucci C; Pierini V; Romoli S; Crescenzi B; Rotoli B; Martelli MF; Pane F; Mecucci C
    Leukemia; 2006 Sep; 20(9):1623-4. PubMed ID: 16838028
    [No Abstract]   [Full Text] [Related]  

  • 4. HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).
    Morerio C; Acquila M; Rosanda C; Rapella A; Dufour C; Locatelli F; Maserati E; Pasquali F; Panarello C
    Cancer Res; 2004 Apr; 64(8):2649-51. PubMed ID: 15087372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
    Crescenzi B; La Starza R; Nozzoli C; Ciolli S; Matteucci C; Romoli S; Rigacci L; Gorello P; Bosi A; Martelli MF; Marynen P; Mecucci C
    Cancer Genet Cytogenet; 2007 Jul; 176(1):67-71. PubMed ID: 17574967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.
    Gallagher G; Horsman DE; Tsang P; Forrest DL
    Cancer Genet Cytogenet; 2008 Feb; 181(1):46-51. PubMed ID: 18262053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib.
    Drechsler M; Hildebrandt B; Kündgen A; Germing U; Royer-Pokora B
    Ann Hematol; 2007 May; 86(5):353-4. PubMed ID: 17211520
    [No Abstract]   [Full Text] [Related]  

  • 8. A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene.
    Gorello P; La Starza R; Brandimarte L; Trisolini SM; Pierini V; Crescenzi B; Limongi MZ; Nanni M; Belloni E; Tapinassi C; Gerbino E; Martelli MF; Foà R; Meloni G; Pelicci PG; Mecucci C
    Leukemia; 2008 Jan; 22(1):216-8. PubMed ID: 17690697
    [No Abstract]   [Full Text] [Related]  

  • 9. KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).
    Levine RL; Wadleigh M; Sternberg DW; Wlodarska I; Galinsky I; Stone RM; DeAngelo DJ; Gilliland DG; Cools J
    Leukemia; 2005 Jan; 19(1):27-30. PubMed ID: 15496975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
    Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
    N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.
    Li Z; Yang R; Zhao J; Yuan R; Lu Q; Li Q; Tse W
    Pediatr Blood Cancer; 2011 Mar; 56(3):463-6. PubMed ID: 21072821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.
    Kobayashi K; Mitsui K; Ichikawa H; Nakabayashi K; Matsuoka M; Kojima Y; Takahashi H; Iijima K; Ootsubo K; Oboki K; Okita H; Yasuda K; Sakamoto H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Ohara A
    Br J Haematol; 2014 Jun; 165(6):836-41. PubMed ID: 24628626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5).
    Ghazzawi M; Mehra V; Knut M; Brown L; Tapper W; Chase A; de Lavallade H; Cross NCP
    Acta Haematol; 2017; 138(4):198-200. PubMed ID: 29169164
    [No Abstract]   [Full Text] [Related]  

  • 14. TV6 and PDGFRB: a license to fuse.
    Lierman E; Cools J
    Haematologica; 2007 Feb; 92(2):145-7. PubMed ID: 17296561
    [No Abstract]   [Full Text] [Related]  

  • 15. KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.
    Medves S; Duhoux FP; Ferrant A; Toffalini F; Ameye G; Libouton JM; Poirel HA; Demoulin JB
    Leukemia; 2010 May; 24(5):1052-5. PubMed ID: 20164854
    [No Abstract]   [Full Text] [Related]  

  • 16. AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis.
    Liu S; Li C; Bo L; Dai Y; Xiao Z; Wang J
    Cancer Genet Cytogenet; 2004 Jul; 152(2):172-4. PubMed ID: 15262442
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2).
    Walz C; Haferlach C; Hänel A; Metzgeroth G; Erben P; Gosenca D; Hochhaus A; Cross NC; Reiter A
    Genes Chromosomes Cancer; 2009 Feb; 48(2):179-83. PubMed ID: 19006078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
    Iriyama N; Takahashi H; Naruse H; Miura K; Uchino Y; Nakagawa M; Iizuka K; Hamada T; Hatta Y; Nakayama T; Takei M
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00591. PubMed ID: 30697976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of FIP1L1 and RARA as a result of a novel t(4;17)(q12;q21) in a case of juvenile myelomonocytic leukemia.
    Buijs A; Bruin M
    Leukemia; 2007 May; 21(5):1104-8. PubMed ID: 17301809
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of chronic myelomonocytic leukemia with severe eosinophilia having t(5;12)(q31;p13) with t(1;7)(q10;p10).
    Kim M; Lim J; Lee A; Park G; Kim Y; Han K; Kang CS; Kim YJ; Song JS
    Acta Haematol; 2005; 114(2):104-7. PubMed ID: 16103634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.